Pillstats
Rx only · Injection, Solution · Intravenous

Clindamycin Phosphate

Brands: Clindamycin · Clindamycin Phosphate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD10AF01
RxCUI (US)2582
US makers2 labelers
Packages11
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.2K2.4K3.5K4.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.6K
Rx · 2026 Q1
133K
Units dispensed
-36%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Baxter Healthcare Corporationunknown10SUPPLYING
Medical Purchasing Solutions, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 21, 2023
    SHORTAGEDrug shortage: Clindamycin Phosphate Injection (Baxter Healthcare)

    Clindamycin Phosphate Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Anti-Infective.